Key stakeholders’ perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa

By sjmartinez • March 24, 2023

Beesham I, Milford C, Joseph Davey DL, Smit J, Mansoor LE, Beksinska M. Key stakeholders' perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa. Afr J AIDS Res. 2023 Mar 23:1-9. doi: 10.2989/16085906.2023.2169177. Epub ahead of print. PMID: 36951406.

Tags: HIV prevention options, Infectious Diseases, post-trial access, PrEP, Publications, standard of prevention

Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections

Singh S, Youssef EG, Barbarino A, Hautau H, Nabeela S, Gebremariam T, Alkhazraji S, Ostroff G, Christensen D, Cochrane T, Ibrahim AS. Next-generation Candida albicans[...]

The Effect of Low Dose Methotrexate on Arterial Inflammation in Persons Living with Human Immunodeficiency Virus. A double-blind randomized placebo-controlled pilot trial

Tawakol A, Ribaudo H, McKhann A, Bellinge JW, Zureigat H, Fayad ZA, Lederman MM, Grinspoon SK, Kuritzkes DR, Stein JH, Ridker PM, Currier JS, Hsue[...]

Associations Between Prior and Current Unhealthy Alcohol Use and Liver Morbidity Risk and Mortality Among Veterans With a History of Hepatitis C Who Have Achieved Sustained Virological Response

Feelemyer J, Ban FK, Braithwaite RS, Bhattacharya D, Caniglia EC, Justice AC, Lim JK, Re VL, Scheidell J, Rentsch CT, Khan M. Associations Between Prior[...]